According to these research studies, the RANK/RANKL pathway shows great stability and reliability in the diagnosis of bone metastases of lung cancer, and RANKL-targeting agents could serve as a rational approach for the prevention of bone metastases (60, 61). The gene discussed is TNFRSF11A; the disease is lung cancer.